Helius Medical Technologies Reports Medicare Reimbursement UpdateNEWDOWNTOPTITLEHelius Medical Technologies, Inc., a Delaware-based company listed on the Nasdaq Stock Market under the symbol HSDT, recently disclosed an important event through an 8-K

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Helius Medical Technologies’s 8K filing here.

About Helius Medical Technologies

(Get Free Report)

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.

Further Reading